Villain; Matteo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Villain; Matteo.The latest application filed is for "purification of polypeptides".

Company Profile

0.8.9

Villain; Matteo - Meyrin CH
Villain; Matteo - Nyon CH
Villain; Matteo - Rancho Palos Verde CA
Villain; Matteo - Geneva CH
Villain; Matteo - Gorla Minore IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Chemical peptide ligation with three or more components Grant 7,884,182 - Botti , et al. February 8, 2	2011-02-08
Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation Grant 7,781,488 - Botti , et al. August 24, 2	2010-08-24
Native chemical ligation with three or more components Grant 7,662,914 - Villain , et al. February 16, 2	2010-02-16
Carboxy protection strategies for acidic C-terminal amino acids in chemical ligation of oligopeptides Grant 7,566,697 - Botti , et al. July 28, 2	2009-07-28
Purification of polypeptides Grant 7,420,035 - Rose , et al. September 2, 2	2008-09-02
Purification Of Polypeptides App 20080194872 - Rose; Keith ; et al.	2008-08-14
Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNs) in a tissue, its selection, pharmaceutical compositions and use Grant 7,410,806 - Nijkamp , et al. August 12, 2	2008-08-12
Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation App 20070059792 - Botti; Paolo ; et al.	2007-03-15
Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNs) in a tissue, its selection, pharmaceutical compositions and use App 20060046963 - Nijkamp; Franciscus Petrus ; et al.	2006-03-02
Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides App 20050261473 - Botti, Paolo ; et al.	2005-11-24
Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNS) in a tissue, its selection, pharmaceutical compositions and use Grant 6,960,565 - Nijkamp , et al. November 1, 2	2005-11-01
Chemical peptide ligation with three or more components App 20050113563 - Botti, Paolo ; et al.	2005-05-26
Native chemical ligation with three or more components App 20050064538 - Villain, Matteo ; et al.	2005-03-24
Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNS) in a tissue, its selection, pharmaceutical compositions and use App 20040176304 - Nijkamp, Franciscus Petrus ; et al.	2004-09-09
Synthetic complementary peptides and ophthalmologic uses thereof Grant 6,762,166 - Haddox , et al. July 13, 2	2004-07-13
Purification of polypeptides App 20030135031 - Rose, Keith ; et al.	2003-07-17
Synthetic complementary peptides and ophthalmologic uses thereof App 20020107202 - Haddox, Jeffrey Lynn ; et al.	2002-08-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.